A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

Authors
Publication date
Publisher
'American Association for the Advancement of Science (AAAS)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1126%2Fscitranslme...
      Last time updated on 21/10/2020